As NanoLabz we were focused on developing and fabricating smart targets for laser-based proton acceleration. Now, as the North-American subsidiary of HIL Applied Medical, we are already working together towards our joint goal - building the world’s first laser- and nanotech-based cancer proton therapy system.
We are excited to be a part of HIL’s world-class, committed and capable team, translating cutting-edge technology into products that will benefit cancer patients worldwide.
Thank you to the University of Nevada Reno, to our investors, shareholders, and friends everywhere, who have helped us along the way.
For more information about the acquisition, please see here.
To learn more about HIL, please go to www.hilappliedmedical.com.